Topic: Precision Medicine in Cardiovascular Diseases and Diabetes

A special issue of Vessel Plus (Online ISSN:2574-1209).

Deadline for manuscript submissions: 30 Jun 2018

Share This Special Issue

Guest Editor(s)

  • Dr. Yunzhou Dong, PhD
    Vascular Biology Program, Department of Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA.

    Website | E-mail

  • Dr. Shengzhong Duan, PhD
    Nutrition and Cardiovascular Biology Program, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, China.

    Website | E-mail

  • Dr. Yanjun Liu, PhD
    Cardiometabolic Research Center, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.

    Website | E-mail

  • Dr. Yong Wu, PhD
    David Geffen School of Medicine at UCLA, Los Angeles, CA 90059, USA.

    Website | E-mail

Special Issue Introduction:

Cardiovascular disease (CVD) and diabetes are devastating and costly diseases. It is predicted that these diseases could exceed billions of people worldwide within the next decades. Although all kinds of drugs have been developed or being developed to prevent and treat CVD and diabetes, neither is highly effective. Precision medicine is the utilization of genetic information to discover individual disease mechanism, and carry out personalized treatments and interventions with specific targeting. With the completion of human genome project and the rapid development of next generation sequencing techniques, rare and common genetic variation as determinants of cardiovascular disease and diabetes susceptibility, diagnostics, and therapeutic response has grown exponentially. The present special issue aims to provide messages about the most recent progress of precision medicine in CVD and diabetes regarding to the precision molecular diagnostics, wearable devices, precision treatment and prognosis.

Keywords:

Cardiovascular disease, diabetes, precision medicine, precision molecular diagnostics, wearable devices, targeted therapy, precision prognosis

Submission Information:

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://vpjournal.net/pages/view/author_instructions
For Online Submission, please login at http://vpjournal.net/login
Submission Deadline: 30 Jun 2018
Contacts: Sylvia Wang, Managing Editor, editorialoffice@vpjournal.net

Published Articles
    This special issue is now open for submission.
Vessel Plus Online ISSN: 2574-1209
Quick Links
  • OAE Publishing Inc. (OAE) is an online open-access publisher specializing in the publication of biomedical peer-reviewed journals...

  • Contact us
  • Leave feedback
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.